U.K.’s MHRA Moves To Implement Restrictions On Prexige Prescribing
Novartis issues “Dear Healthcare Professional” letter advising physicians to conduct regular liver function tests on patients using the COX-2 inhibitor.
Novartis issues “Dear Healthcare Professional” letter advising physicians to conduct regular liver function tests on patients using the COX-2 inhibitor.